Past ARDS Speakers
“The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.”
David Parke, II
Records per page:
2012 40th Annual Meeting
J. Brooks Crawford, MDIs Ocular Pathology Still Relevant to Clinical Ophthalmology?
Donald J. D'Amico, MDSurgical Management of Severe Macular Edema
Pravin U. Dugel, MDAnti-PDGF Combination Treatment for nvAMD: Beyond Anti-VEGF Monotherapy
Pravin U. Dugel, MDEpimacular Brachytherapy for nvAMD: The CABERNET and MERITAGE Studies
Szilárd Kiss, MDAnti-VEGF Gene Therapy for the Treatment of ARMD
David W. Parke, II, MDRisk Mitigation in Vitreoretinal Surgery Practice: True Stories
Carl D. Regillo, MDManagement of Retained Lens Material
Carl D. Regillo, MDRecent Developments in Neovascular AMD Treatment
Giovanni Staurenghi, MDAdvances in SD-OCT Examination of Retinal Diseases
Giovanni Staurenghi, MDAlternate Views of the Fundus: Current Experience with Autofluorescence, Indocyanine Green Angiography, and Infrared Imaging
George A. Williams, MDHealth Care Reform 2012
George A. Williams, MDRetinal Neuroprotection
2011 39th Annual Meeting
Robert L. Avery, MDRetinal Detachment Repair: To Buckle or Not. Success Rates from a Single Private Practice
Robert L. Avery, MDVitrectomy and Pars Plana Baerveldt Glaucoma Implants for Complex Glaucoma
Mina Chung, MDFamilial Exudative Vitreoretinopathy — Case Report and Genetics
Mina Chung, MDRetinal Complications of the Dohlman Keratoprosthesis
Carl Claes, MDOcular Trauma Surgery: Surgical Video Review/Presentation
Carl Claes, MDPediatric Surgery: Surgical Video Review/Presentation
Harry W. Flynn, Jr., MDEndophthalmitis after Intravitreal Anti-VEGF Injections: 6 Years Rates and Outcomes of Treatment at BPEI
Harry W. Flynn, Jr., MDThe New Paradigm for Treatment of DME in the Anti-VEGF Era: An Assessment of the Risks, Benefits, and Costs
K.Bailey Freund, MDAcquired Vitelliform Lesions: Correlation of Clinical Findings and Multiple Imaging Analyses
K.Bailey Freund, MDDo We Need a New Classification for Choroidal Neovascularization in Age-related Macular Degeneration
Andre V. Gomes, MD, PhDPVR and Retinotomies: How Far Should We Go?
Andre V. Gomes, MD, PhDSurgical Management of Idiopathic Macular Holes in the SD-OCT Era
Allen C. Ho, MDMicroincision Vitrectomy 2011: New Instrumentation and Techniques
PREV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 NEXT